Current thoughts on the role of chemotherapy and radiation in advanced head and neck cancer

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 12, Issue 2, 2004, Pages 82-87

  Moyer, Jeffrey S ^a   Wolf, Gregory T ^a   Bradford, Carol R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Chemotherapy; Head and neck cancer; Organ preservation; Radiation; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNGECTOMY; LARYNX CANCER; METASTASIS; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CANCER; ORGAN PRESERVING THERAPY; OROPHARYNX CANCER; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE;

CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS, PHASE III; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; NASOPHARYNGEAL NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OROPHARYNGEAL NEOPLASMS;

EID: 1842486156     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200404000-00005     Document Type: Review

References (25)

1. Jacobs C, Goffinet DR, Goffinet L, et al.: Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer 1987, 60:1178-1183.
2. Karp DD, Vaughan CW, Carter R, et al.: Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report. Am J Clin Oncol 1991, 14:273-279.
3. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991, 324:1685-1690.
4. Wolf GT: Chemotherapy for laryngeal cancer. In Diseases of the Larynx. Edited by Ferlito A. London: Arnold Publishers; 2000:709-725.
5. Hillman RE, Walsh M, Wolf GT, et al.: Functional outcomes following treatment for advanced laryngeal cancer: part 1: voice preservation in advanced laryngeal cancer. Ann Otol Rhinol Laryngol 1998, 107(suppl 172).
6. Terrell JE, Fisher SG, Wolf GT, et al.: Long term quality of life after treatment for laryngeal cancer. Arch Otolaryngol Head Neck Surg 1998, 124:964-971.
7. Smith RV, Katz T, Beitler JJ, et al.: Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea. Arch Otolaryngol Head Neck Surg 2000, 126:384-389.
8. Eisbruch A, Lyden T, Bradford CR, et al.: Objective assessment of swallowing dysfunction and aspiration following radiation concurrent with chemotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2002, 53:23-28.
9. Forastiere AA, Berkey B, Maor M, et al.: Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, Intergroup Trial R91-11 [abstract]. Proc Am Soc Clin Oncol 2001, 20:2a.
10. Weber RS, Berkey BA, Forastiere AA, et al.: Outcome of salvage laryngectomy following organ preservation therapy. Arch Otolaryngol Head Neck Surg 2003, 129:44-49. This important article prospectively examines morbidity after concurrent chemoradiation.
11. Wolf GT, Bradford CR, Urba S, et al.: Immune reactivity does not predict chemotherapy response, organ preservation, or survival in advanced laryngeal cancer. Laryngoscope 2002, 112:1351-1356. This study documents an unexpectedly high 2-year survival rate in patients with advanced laryngeal cancer treated with concurrent chemoradiation after selection with one cycle of neoadjuvant chemotherapy.
12. Laccourreye O, Veivers D, Hans S, et al.: Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders. Cancer 2001, 92:1504-1511.
13. Laccourreye O, Veivers D, Hans S, et al.: Analysis of local recurrence in patients with selected T1-T3N0M0 squamous cell carcinoma of the true vocal cord managed with a platinum-based chemotherapy-alone regimen for cure. Ann Otol Rhinol Laryngol 2002, 111:315-321.
14. Lefebvre JL, Chevalier D, Luboinski B, et al.: Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996, 88:890-899.
15. Pignon JP, Bourhis J, Domenge C, et al.: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000, 355:949-955.
16. Browman GP, Hodson DI, Mackenzie RJ, et al.: Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 2001, 23:579-589.
17. Domenge C, Hill C, Lefebvre JL, et al.: Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. Br J Cancer 2000, 83:1594-1598.
18. Paccagnella A, Orlando A, Marchiori C, et al.: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994, 86:265-272.
19. Calais G, Alfonsi M, Bardet E, et al.: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-staged oropharynx carcinoma. J Natl Cancer Inst 1999, 91:2081-2086.
20. Machtay M, Rosenthal DI, Hershock D, et al.: Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial. J Clin Oncol 2002, 20:3964-3971. This phase II study demonstrated improved 3-year survival rates compared with historical controls (surgery/radiation) in patients with oropharyngeal cancer treated with neoadjuvant chemotherapy and concurrent chemoradiation.
21. Al-Sarraf M, LeBlanc M, Giri PGS, et al.: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III Randomized Intergroup Study 0099. J Clin Oncol 1998, 16:1310-1317.
22. Lin JC, Jan JS, Hsu CY, et al.: Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003, 21:631-637. This important phase III study demonstrates a significant impact of concurrent chemoradiation on survival for patients with advanced nasopharyngeal carcinoma treated in endemic regions.
23. Merlano M, Benasso M, Corvo R, et al.: Five-year update of a randomized trial alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996, 88:583-589.
24. Brizel DM, Albers ME, Fisher SR, et al.: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998, 338:1798-1804.
25. Adelstein DJ, Adams GL, Wagner H, et al.: An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003, 21:92-98. This phase III study documents improved survival in patients with unresectable disease treated with concurrent chemoradiation when compared with radiation alone.